Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Xtant Medical Holdings (XTNT) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.

  • Xtant Medical Holdings' Change in Receivables fell 12035.71% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year increase of 24485.42%. This contributed to the annual value of $755000.0 for FY2024, which is 9135.76% down from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Change in Receivables is -$1.2 million, which was down 12035.71% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Change in Receivables ranged from a high of $3.9 million in Q3 2023 and a low of -$1.2 million during Q3 2025
  • For the 5-year period, Xtant Medical Holdings' Change in Receivables averaged around $1.0 million, with its median value being $903000.0 (2021).
  • In the last 5 years, Xtant Medical Holdings' Change in Receivables tumbled by 21560.69% in 2021 and then soared by 206806.28% in 2025.
  • Over the past 5 years, Xtant Medical Holdings' Change in Receivables (Quarter) stood at $903000.0 in 2021, then grew by 8.42% to $979000.0 in 2022, then soared by 72.52% to $1.7 million in 2023, then crashed by 62.88% to $627000.0 in 2024, then tumbled by 296.81% to -$1.2 million in 2025.
  • Its Change in Receivables stands at -$1.2 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.1 million for Q1 2025.